The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
The Heart in Human Dystrophinopathies
Abstract
Dystrophinopathies are due to mutations in the dystrophin gene on chromosome Xp21.1 and comprise the allelic entities Duchenne muscular dystrophy (DMD), Becker muscular dystrophy (BMD) and X-linked dilative cardiomyopathy (XLDCM). In all three entities, the heart is affected to various degrees, depending on the stage of the disease and the type of the mutation (cardiac involvement, CI). The pathoanatomic evidence of CI in dystrophinopathies is the replacement of myocardium by connective tissue or fat. In DMD/BMD, the left ventricular posterobasal and lateral walls are most extensively affected, sparing the right ventricle and the atrium. Degree and dynamics of CI vary among the three entities. In DMD/BMD, CI usually remains subclinical in the early stages of the disease. Typical initial manifestations of CI in DMD/BMD are sinus tachycardia, tall R1 in V1, prominent Q in I, aVL, V6 or in II, III, and aVF, increased QT dispersion and possibly autonomic dysfunction. Initially, echocardiography is normal or shows regional wall motion abnormalities in areas of fibrosis. With spreading of fibrosis, left ventricular dysfunction and ventricular arrhythmias additionally occur. In the final stages of the disease, systolic function may lead to heart failure and sudden death. Subclinical or clinical CI is present in about 90% of the DMD/BMD patients but is the cause of death in only 20% of the DMD and 50% of the BMD patients. XLDCM is a rapidly progressive, almost exclusively myocardial disorder, starting in teenage males as heart failure due to dilative cardiomyopathy (CMP), leading to death from intractable heart failure within 1–2 years after diagnosis. Therapy of arrhythmias and CMP in all three disorders follows the established cardiological recommendations. Due to its protective effect, ACE inhibitors are recommended already at the early stages of the disease. β-Blockers may be an additional option if indicated.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Emery, A. E. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07815-7 · Cited by 1,667
Gregoratos, G., Abrams, J., Epstein, A. E., Freedman, R. A., Hayes, D. L., Hlatky, M. A., Kerber, R. E., Naccarelli, G. V., Schoenfeld, M. H., Silka, M. J., et al. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02528-7 · Cited by 1,266
The incidence and evolution of cardiomyopathy in Duchenne muscular dystrophy
Nigro, G., Comi, L. I., Politano, L., & Bain, R. J. I. (1990) · International Journal of Cardiology · doi:10.1016/0167-5273(90)90082-g · Cited by 731
(1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00024-2 · Cited by 632
Towbin, J. A., Hejtmancik, J. F., Brink, P., Gelb, B., Zhu, X. M., Chamberlain, J. S., McCabe, E. R., & Swift, M. (1993) · Circulation · doi:10.1161/01.cir.87.6.1854 · Cited by 516
Deletion of the Dystrophin Muscle-Promoter Region Associated with X-Linked Dilated Cardiomyopathy
Muntoni, F., Cau, M., Ganau, A., Congiu, R., Arvedi, G., Mateddu, A., Marrosu, M. G., Cianchetti, C., Realdi, G., Cao, A., et al. (1993) · New England Journal of Medicine · doi:10.1056/nejm199309233291304 · Cited by 416
Duchenne muscular dystrophy: Patterns of clinical progression and effects of supportive therapy
Brooke, M. H., Fenichel, G. M., Griggs, R. C., Mendell, J. R., Moxley, R., Florence, J., King, W. M., Pandya, S., Robison, J., Schierbecker, J., et al. (1989) · Neurology · doi:10.1212/wnl.39.4.475 · Cited by 353
Bushby, K., Muntoni, F., & Bourke, J. P. (2003) · Neuromuscular Disorders · doi:10.1016/s0960-8966(02)00213-4 · Cited by 300
The pathology of the heart in progressive muscular dystrophy: Epimyocardial fibrosis
Frankel, K. A., & Rosser, R. J. (1976) · Human Pathology · doi:10.1016/s0046-8177(76)80053-6 · Cited by 287
The role of cytoskeletal proteins in cardiomyopathies
Towbin, J. A. (1998) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(98)80096-3 · Cited by 273
Cox, G. F., & Kunkel, L. M. (1997) · Current Opinion in Cardiology · doi:10.1097/00001573-199705000-00015 · Cited by 257
The distinctive electrocardiogram of Duchenne's progressive muscular dystrophy
Perloff, J. K., Roberts, W. C., de Leon, A. C., & O'Doherty, D. (1967) · The American Journal of Medicine · doi:10.1016/0002-9343(67)90017-4 · Cited by 245
Evidence for a Dystrophin Missense Mutation as a Cause of X-Linked Dilated Cardiomyopathy
Ortiz-Lopez, R., Li, H., Su, J., Goytia, V., & Towbin, J. A. (1997) · Circulation · doi:10.1161/01.cir.95.10.2434 · Cited by 182
Cardiac and Pulmonary Complications in Duchenne's Progressive Muscular Dystrophy
GILROY, J., CAHALAN, J. L., BERMAN, R., & NEWMAN, M. (1963) · Circulation · doi:10.1161/01.cir.27.4.484 · Cited by 163
Perloff, J. K., Henze, E., & Schelbert, H. R. (1984) · Circulation · doi:10.1161/01.cir.69.1.33 · Cited by 159
Corrado, G., Lissoni, A., Beretta, S., Terenghi, L., Tadeo, G., Foglia-Manzillo, G., Tagliagambe, L. M., Spata, M., & Santarone, M. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)02195-1 · Cited by 158
Griffin, J. L., Williams, H. J., Sang, E., Clarke, K., Rae, C. D., & Nicholson, J. K. (2001) · Analytical Biochemistry · doi:10.1006/abio.2001.5096 · Cited by 152
Comi, G. P., Prelle, A. C., Bresolin, N., Moggio, M. G., Bardoni, A., Gallanti, A., Vita, G., Toscano, A., Ferro, M. T., Bordoni, A., et al. (1994) · Brain · doi:10.1093/brain/117.1.1-a · Cited by 146
Cardiac and respiratory involvement in advanced stage Duchenne muscular dystrophy
Melacini, P., Vianello, A., Villanova, C., et al. (1996) · Neuromuscular Disorders · doi:10.1016/0960-8966(96)00357-4 · Cited by 145
James, T. N. (1962) · American Heart Journal · doi:10.1016/0002-8703(62)90219-3 · Cited by 145
Evaluation of the cardiomyopathy in becker muscular dystrophy
Nigro, G., Comi, L. I., Politano, L., Limongelli, F. M., Nigro, V., Rimini, M. L. D., Giugliano, M. A. M., Petretta, V. R., Passamano, L., Restucci, B., et al. (1995) · Muscle & Nerve · doi:10.1002/mus.880180304 · Cited by 140
Cardioprotection for Duchenne’s muscular dystrophy
Ishikawa, Y., Bach, J. R., & Minami, R. (1999) · American Heart Journal · doi:10.1016/s0002-8703(99)70414-x · Cited by 139
Cardiac involvement in becker muscular dystrophy
Melacini, P., Fanin, M., Danieli, G. A., Fasoli, G., Villanova, C., Angelini, C. I., Vitiello, L., Miorelli, M., Buja, G., Mostacciuolo, M. L., et al. (1993) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(93)90781-u · Cited by 133
Grain, L., Cortina‐Borja, M., Forfar, C., Hilton‐Jones, D., Hopkin, J. M., & Burch, M. (2001) · Neuromuscular Disorders · doi:10.1016/s0960-8966(00)00185-1 · Cited by 130
Clinical studies in benign (Becker type) X‐linked muscular dystrophy
Emery, A. E. H., & Skinner, R. (1976) · Clinical Genetics · doi:10.1111/j.1399-0004.1976.tb00033.x · Cited by 123
Ventricular arrhythmia in Duchenne muscular dystrophy: Prevalence, significance and prognosis
Chénard, A., Bécane, H. M., Tertrain, F., Kermadec, J. M. D., & Weiss, Y. (1993) · Neuromuscular Disorders · doi:10.1016/0960-8966(93)90060-w · Cited by 111
Kermadec, J. M. D., Bécane, H.-M., Chénard, A., Tertrain, F., & Weiss, Y. A. (1994) · American Heart Journal · doi:10.1016/0002-8703(94)90672-6 · Cited by 109
Yoshida, K., Nakamura, A., Yazaki, M., Ikeda, S., & Takeda, S. (1998) · Human Molecular Genetics · doi:10.1093/hmg/7.7.1129 · Cited by 98
Dystrophin gene abnormalities in two patients with idiopathic dilated cardiomyopathy
Muntoni, F., Lenarda, A. D., Porcu, M., Sinagra, G., Mateddu, A., Marrosu, G., Ferlini, A., Cau, M., Milašin, J., Melis, M. A., et al. (1997) · Heart · doi:10.1136/hrt.78.6.608 · Cited by 94
Cardiac dysfunction with Becker muscular dystrophy
Saito, M. H., Kawai, H., Akaike, M., Adachi, K., Nishida, Y., & Saito, S. (1996) · American Heart Journal · doi:10.1016/s0002-8703(96)90250-1 · Cited by 93
Sequence of cardiac changes in Duchenne muscular dystrophy
Heymsfield, S. B., McNish, T., Perkins, J. V., & Felner, J. M. (1978) · American Heart Journal · doi:10.1016/0002-8703(78)90358-7 · Cited by 90
THE ELECTROCARDIOGRAM IN PROGRESSIVE MUSCULAR DYSTROPHY
Manning, G. W., & Cropp, G. J. A. (1958) · Heart · doi:10.1136/hrt.20.3.416 · Cited by 88
The heart in progressive muscular dystrophy
Rubin, I. L., & Buchberg, A. S. (1952) · American Heart Journal · doi:10.1016/0002-8703(52)90208-1 · Cited by 87
The heart in becker muscular dystrophy, facioscapulohumeral dystrophy, and bethlem myopathy
de Visser, M., de Voogt, W. G., & la Rivière, G. A. V. (1992) · Muscle & Nerve · doi:10.1002/mus.880150510 · Cited by 84
The Electrocardiogram in Duchenne Progressive Muscular Dystrophy
Slucka, C. (1968) · Circulation · doi:10.1161/01.cir.38.5.933 · Cited by 82
Circadian rhythm and variability of heart rate in Duchenne-type progressive muscular dystrophy
Yotsukura, M., Sasaki, K., Kachi, E., Sasaki, A., Ishihara, T., & Ishikawa, K. (1995) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)80267-7 · Cited by 82
Muntoni, F., Melis, M., Ganau, A., & Dubowitz, V. (1995) · Europe PMC (PubMed Central) · Cited by 79
Cardiomyopathy of Duchenne muscular dystrophy
D’Orsogna, L., O’Shea, J. P., & Miller, G. (1988) · Pediatric Cardiology · doi:10.1007/bf02078410 · Cited by 73
Franz, W., Muller, M., Müller, O. J., Herrmann, R., Rothmann, T., Cremer, M., Cohn, R. D., Voït, T., & Katus, H. A. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02266-2 · Cited by 70
Evolution of cardiac abnormalities in Becker muscular dystrophy over a 13-year period
Hoogerwaard, E. M., de Voogt, W. G., Wilde, A. A. M., van der Wouw, P. A., Bakker, E., van Ommen, G. B., & de Visser, M. (1997) · Journal of Neurology · doi:10.1007/s004150050163 · Cited by 69
Echocardiographic evaluation of left ventricular function in Duchenne's muscular dystrophy
Farah, M. G., Evans, E. B., & Vignos, P. J. (1980) · The American Journal of Medicine · doi:10.1016/0002-9343(80)90385-x · Cited by 68
Porreca, E., Guglielmi, M. D., Uncini, A., Gregorio, P. D., Angelini, A., Febbo, C. D., Pierdomenico, S. D., Baccante, G., & Cuccurullo, F. (1999) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1614521 · Cited by 67
Clinical and Experimental Results on Cardiac Troponin Expression in Duchenne Muscular Dystrophy
Hammerer‐Lercher, A., Erlacher, P., Bittner, R. E., Korinthenberg, R., Skladal, D., Sorichter, S., Sperl, W., Puschendorf, B., & Mair, J. (2001) · Clinical Chemistry · doi:10.1093/clinchem/47.3.451 · Cited by 67
Bies, R. D., Maeda, M., Roberds, S. L., et al. (1997) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1997.0568 · Cited by 57
Magnetic resonance spectroscopy evidence of abnormal cardiac energetics in Xp21 muscular dystrophy
Crilley, J. G., Boehm, E. A., Rajagopalan, B., Blamire, A. M., Styles, P., Muntoni, F., Hilton‐Jones, D., & Clarke, K. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00960-8 · Cited by 56
Angelini, C. I., Fanin, M., Pegoraro, E., Freda, M. P., Cadaldini, M., & Martinello, F. (1994) · Neuromuscular Disorders · doi:10.1016/0960-8966(94)90071-x · Cited by 54
Pathogenesis of Inherited Forms of Dilated Cardiomyopathy
Graham, R. M., & Owens, W. A. (1999) · New England Journal of Medicine · doi:10.1056/nejm199912023412309 · Cited by 50
Serial two‐dimensional echocardiography in Duchenne muscular dystrophy
Goldberg, S. J., Stern, L. Z., Feldman, L., Allen, H. D., Sahn, D. J., & Valdes‐Cruz, L. M. (1982) · Neurology · doi:10.1212/wnl.32.10.1101 · Cited by 49
Dilating cardiomyopathy as the expression of Xp21 Becker type muscular dystrophy
Palmucci, L., Doriguzzi, C., Mongini, T., Chiado'-Piat, L., Restagno, G., Carbonara, A. O., & Paolillo, V. (1992) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(92)90073-t · Cited by 44
Ducceschi, V., Nigro, G., Sarubbi, B., Comi, L. I., Politano, L., Petretta, V. R., Nardi, S., Briglia, N., Santangelo, L., Nigro, G., et al. (1997) · International Journal of Cardiology · doi:10.1016/s0167-5273(97)02933-1 · Cited by 41
Nagai, T. (1989) · Japanese Circulation Journal-english Edition · doi:10.1253/jcj.53.406 · Cited by 34
Cardiac Involvement in Progressive Muscular Dystrophy of the Duchenne Type.
Ishikawa, K. (1997) · Japanese Heart Journal · doi:10.1536/ihj.38.163 · Cited by 33
Becker Muscular Dystrophy with Bundle Branch Reentry Ventricular Tachycardia
Negri, S., & Cowan, M. (1998) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.1998.tb00949.x · Cited by 31
Echocardiography in duchenne muscular dystrophy
Danilowicz, D., Rutkowski, M., Ma, D. M., & Schievely, D. (1980) · Muscle & Nerve · doi:10.1002/mus.880030405 · Cited by 25
The cardiomyopathy of Duchenne's muscular dystrophy and the function of dystrophin
Cziner, D. G., & Levin, R. I. (1993) · Medical Hypotheses · doi:10.1016/0306-9877(93)90206-6 · Cited by 24
Ferlini, A., & Muntoni, F. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.7976 · Cited by 22
Hoogerwaard, E. M., Schouten, Y., van der Kooi, A. J., Gorgels, J. P. M. C., de Visser, M., & Sanders, G. T. (2001) · Clinical Chemistry · doi:10.1093/clinchem/47.5.962 · Cited by 16
Matsuoka, S., Ii, K., Akita, H., Tomimatsu, H., KURAHASHI, Y., Nakatsu, T., & Miyao, M. (1987) · Japanese Heart Journal · doi:10.1536/ihj.28.687 · Cited by 15
Could Utrophin Rescue the Myocardium of Patients with Dystrophin Gene Mutations?
Fanin, M., Melacini, P., Angelini, C. I., & Danieli, G. A. (1999) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1999.0987 · Cited by 13
Systolic time intervals in duchenne muscular dystrophy: evaluation of left ventricular performance
Chénard, A., Bécane, H. M., Tertrain, F., & Weiss, Y. (1988) · Clinical Cardiology · doi:10.1002/clc.4960110609 · Cited by 9
Cited by
Respiratory Care of the Patient with Duchenne Muscular Dystrophy: ATS Consensus Statement
(2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200307-885st · Cited by 733
Myofibroblast-mediated mechanisms of pathological remodelling of the heart
Weber, K. T., Sun, Y., Bhattacharya, S. K., Ahokas, R. A., & Gerling, I. C. (2013) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2012.158 · Cited by 673
The Dystrophin Glycoprotein Complex: Signaling Strength and Integrity for the Sarcolemma
Lapidos, K. A., Kakkar, R., & McNally, E. M. (2004) · Circulation Research · doi:10.1161/01.res.0000126574.61061.25 · Cited by 524
TGF-β Family Signaling in Tumor Suppression and Cancer Progression
Seoane, J., & Gomis, R. R. (2017) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a022277 · Cited by 510
Small and large animal models in cardiac contraction research: advantages and disadvantages
Milani-Nejad, N., & Janssen, P. M. L. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.10.007 · Cited by 484
Metadata
- Authors
- Finsterer, J., & Stöllberger, C.
- Venue
- Cardiology
- Publisher
- S. Karger AG
- Published
- 2003
- Volume
- 99
- Issue
- 1
- Pages
- 1-19
- ISSN
- 0008-6312 (ISSN-L)
- 1421-9751
- OpenAlex
- W2051741101
- Cited by
- 439
- References
- 60
- FWCI
- 11.94
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.